ABSTRACT
IntroductIon
Hemostatic agents have been used since many years in different surgical procedures 4, 6, 11 . In the 1940s gelatin sponge or Gelfoam® (Pfizer Inc, New York -USA) was first introduced in neurosurgery. Surgicel® (Johnson & Johnson medicalBrazil), an absorbable oxidized regenerated cellulose derived from alpha-cellulose, is widely used as hemostatic agent in neurosurgery. It works in the intrinsic pathway of clotting causing contact activation and has a relative antibacterial activity when compared to Gelfoam® and topical thrombin.3 It is bioabsorbable and may be left in the surgical bed. Its postoperative appearances were studied with X-rays, ultrasonographic studies and CT-scan 9, 16, 17 . Early in the postoperative period Surgicel® may mimic an abscess on both MRI and sonography 10 . There are very few reports on the appearance of Surgicel® on postoperative magnetic resonance imaging (MRI) in neurosurgery 10, 15 . In the last years intraoperative MRI has become the golden standard in surgery of cerebral gliomas 12 . This method increases the possibility of radical removal and safety in surgery of these lesions. The objectives of our study were to describe the appearance of Surgicel® on intraoperative MRI and its use as marker of resection borders during the surgery. There is no report in the literature describing the features of Surgicel® on intraoperative MRI during neurosurgical procedures.
MaterIal and Methods
This prospective study evaluates the appearance and the reliability of using Surgicel® as marker of resection borders during intraoperative MRI in a series of 72 patients operated on cerebral gliomas. Thirty-two patients presented low-grade gliomas and 40 patients high-grade gliomas. After tumor resection careful hemostasis was performed and Surgicel® was placed covering the entire tumor bed in a monolayer fashion. Intraoperative high field MRI (1.5 T, GE-Excite, USA) was performed. Our protocol studied the following MRI sequences: a) Low-grade non-enhancing gliomas: T1, T2, T2-SWI (Susceptibility Weighted Imaging) and FLAIR (Fast fluid-attenuated inversion-recovery) with no gadolinium injection, b) High-grade and enhancied low-grade gliomas: T1 with gadolinium, T2, FLAIR and T2-SWI with no gadolinium injection. All intraoperative MR examinations were followed by the surgeons and neuroradiologists. Characteristics of Surgicel® on MRI and the validity of its use as marker of tumor resection borders showing eventually residual lesion under the monolayer of Surgicel® were registered.
Results
Studying 72 operated cerebral gliomas we have observed that Surgicel® presented a hyperintense signal in T1 contrasting with the very thin hypointense signal over the tumor resection bed observed during intraoperative MRI ( Figure 1 ). Sequences T2, SWI and FLAIR with or with no gadolinium injection could not clearly define the Surgicel® layer. Figure 2 shows a comparison of the studied MRI sequences. The T1 sequence without gadolinium injection was the best sequence to delineate the monolayer of Surgicel®. In this series Surgicel® used as marker of tumor resection borders was useful during removal of high-grade gliomas ( Figure 3 ) as well as of low-grade gliomas ( Figure 4) . Twenty-three patients (33%) underwent additional tumor removal after intraoperative MRI. agents in neurosurgery due to its hemostatic and proven bactericidal properties against a broad range of gram-positive and gram-negative organisms 1, 3, 14 . It has a relatively low pH which causes some small vessel contraction and inflammatory reaction. Damage to the endothelium exposes collagen causing platelet aggregation and adhesion. Surgicel® may promote a foreign body reaction and a granuloma formation as result of inflammatory reaction and macrophages action. These reactions to Surgicel® may mimicking a tumor recurrence or brain abscess in imaging studies 2, 7 . Grade of tumor resection has been demonstrated to be one of the most important prognostic factors in outcome of patients harboring lowgrade or high-grade gliomas 8, 13 . Intraoperative MRI has become the most valuable tool to assure intraoperatively the extension of tumor removal in cerebral glioma patients 10 .
Tumor volume resection is usually better evaluated in T1 sequence with gadolinium enhanced tumors and FLAIR and T2 with gadolinium non-enhanced lesions. A marker showing tumor resection borders during intraoperative MRI helps the evaluation of the extension of tumor removal in both groups of patients. The appearance of Surgicel® on the intraoperative MRI was of a lining with hyperintense signal in T1 sequence covering the entire surgical field. This finding was constant in all patients of this series and could help to identify tumor remnants under the hemostatic agent layer. The postoperative MRI, 24hs after the procedure, showed hyperintense signal within the resection cavity and the Surgicel® layer could not be so well observed as during the intraoperative MRI (Figure  3 B) . T2-SWI MRI sequences usually can show very well hemoglobin degradation products, but during surgery the presence of air bubbles and blood within the surgical cavity may produce a "blooming" artifact and the Surgicel® layer will not be well delineated (Figure 4 C) . Spiller et al have demonstrated that Surgicel® in vitro presented a hyperintense signal in MRI-T1 sequence 15 . According to these authors this hemostatic agent accelerates the oxidation of oxihemoglobin to metahemoglobin. Oxihemoglobin is diamagnetic (hypointense signal in T1 sequences) and metahemoglobin is paramagnetic (hyperintense signal in T1 sequences). These signal differences of hemoglobin are also observed when the different phases of an intracerebral hematoma are studied with MRI They found the hypointense signal in T2 sequence as the best marker of resection borders. In the abdominal cavity there is a large amount of fat tissue around the organs and probably a better visualization of the hypointense signal produced by the Surgicel® in the postoperative MRI will be better observed in T2 sequences. They also described the hyperintense signal in T1 as postoperative fluid artifact 10 . In our opinion, due to the fact that brain has no fat issue, T1 sequences are more appropriated to visualize the Surgicel® layer. We could not find in the literature any description of the appearance of Surgicel® during intraoperative MRI for cerebral gliomas surgery.
conclusIon
The appearance of Surgicel® in the resection borders of cerebral gliomas in T1-MRI is of a hyperintense layer. This hemostatic agent accelerates the oxidation of oxyhemoglobin to metahemoglobin that is paramagnetic and has a hyperintense signal in MRI-T1 sequences. This layer of Surgicel® may be a useful marker of tumor resection borders in cerebral glioma surgery.
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